Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: No elaboration on Germany in the Shareholder Letter

No elaboration on Germany in the Shareholder Letter

posted on Feb 09, 2009 11:35AM

I've got to think that RG purposely did not elaborate on Germany. I wish I knew the reasoning. I would guess that the "majority" of his recent shareholder questions were related to the German ruling.

Share
New Message
Please login to post a reply